KMT2C
Top View
- Pancreatic Cancer: "A Riddle Wrapped in a Mystery Inside an Enigma" Erkut Borazanci1, Chi V
- SUPPLEMENTARY APPENDIX Exome Sequencing Reveals Heterogeneous Clonal Dynamics in Donor Cell Myeloid Neoplasms After Stem Cell Transplantation
- Comprehensive Multi-Omics Integration Identifies Differentially Active Enhancers During Human Brain Development with Clinical Relevance
- A System for Detecting High Impact-Low Frequency Mutations in Primary Tumors and Metastases
- Mutational and Functional Analyses of Kabuki Syndrome Genes Demonstrate Critical Roles in Craniofacial, Heart and Brain Developm
- KMT2D Regulates P63 Target Enhancers to Coordinate Epithelial Homeostasis
- Pan-Cancer Multi-Omics Analysis and Orthogonal Experimental Assessment of Epigenetic Driver Genes
- Recombinant KMT2C (MLL3) Complex Catalog No: 31478, 31878 Quantity: 20 Μg Lot No: 21815002 Concentration: 1.4 Μg/Μl Expressed In: E
- Structure, Activity and Function of the MLL2 (KMT2B) Protein Lysine Methyltransferase
- Somatic Mutations in the Human Brain: Implications for Psychiatric Research
- Regulating Methylation at H3K27: a Trick Or Treat for Cancer Cell Plasticity
- In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype
- Whole Genome Analysis As a Tool for Diagnosis in Silver-Russell
- Supplemental Material 1
- A Tumorigenic Index for Quantitative Analysis of Liver Cancer Initiation and Progression
- Genomic Profiling of Primary Histiocytic Sarcoma Reveals Two Molecular
- Deletion of Kmt2c in Neurons of Mice Causes Multiple Neurobehavioral Abnormalities
- FOXA1 Upregulation Promotes Enhancer and Transcriptional Reprogramming in Endocrine-Resistant Breast Cancer